跳至主要内容
临床试验/NCT00628368
NCT00628368已完成不适用

Study to Analyze the Predictive Role of Factors Implicated in the Signaling Pathway of the EGFR in Response to Treatment With Neoadjuvant Chemoradiotherapy in Patients With Cancer of the Esophagus or Rectum

Institut du Cancer de Montpellier - Val d'Aurelle1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2005年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
160
试验地点
1
主要终点
Determination of predictive factors in the EGFR signaling pathway in response to treatment

研究概览

简要总结

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.

PURPOSE: This clinical trial is studying how well biological factors work in predicting response to treatment in patients with esophageal cancer or rectal cancer.

详细描述

OBJECTIVES:

Primary

  • Analyze various biological factors that can be used as markers to predict response to treatment and correlate with the signaling pathway of EGFR.

Secondary

  • Establish a tissue bank to store information about the response to treatment and survival.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • DISEASE CHARACTERISTICS:
  • Histologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus or rectum
  • Planning to receive neoadjuvant treatment, including radiotherapy or chemoradiotherapy
  • PATIENT CHARACTERISTICS:
  • Not pregnant or nursing
  • No blood disorder
  • Not deprived of freedom or protected by law
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics

排除标准

  • 未提供

研究组 & 干预措施

Experimental: Rectal and oesophagus cancer

Experimental

Additionnal samples from routine care (tumor tissue and healthy tissue and one blood tube) and standardized clinical data will be entered into a database.

干预措施: Gene expression analysis (Genetic)

结局指标

主要结局

Determination of predictive factors in the EGFR signaling pathway in response to treatment

时间窗: End of study : approximately 4 years

次要结局

未报告次要终点

研究者

发起方
Institut du Cancer de Montpellier - Val d'Aurelle
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Biological Factors in Predicting Response to... | 临床试验